Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
72 participants
INTERVENTIONAL
2019-09-01
2033-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Partially-guided Protocol for Maxillary Overdentures Retained by Ti-Zr One-piece Mini Implants
NCT06081192
Mandibular Overdentures Retained by Mini Implants: a Clinical Trial Comparing Different Surgical and Loading Protocols
NCT04760457
Comparison of Clinical Performance and Safety of Zirconia vs. Titanium Implants: a Multi-national RCT.
NCT03908177
Outcome of Implant-supported Overdentures
NCT03777748
Zirconia Implants for Replacement of a Single Tooth
NCT04695899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control-group
Two Tissue Level TiZr Sand blasted long grit acid-etched (SLA) implants placed in positions 33 and 43 (diameter 3.3mm, length ≥10mm), early loading
early loading
two TiZr implants on SLA surface
Experimental-group
Four narrow-diameter implants (NDI) TiZr SLA implants in positions 34, 32, 42, and 44 (diameter 2.4mm, length ≥10mm), immediate loading
immediate loading
four TiZr implants on SLA surface
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
early loading
two TiZr implants on SLA surface
immediate loading
four TiZr implants on SLA surface
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
* Age ≥ 18 years
* Sufficient complete dentures (Marxkors and Ferger, 1989) not older than 1 year
* Patient is unsatisfied with mandibular denture to the degree that he/she seeks treatment
* At site level:
* Healed edentulous mandible (minimum 8 weeks since last extraction)
* Minimal ridge dimensions 5.5 mm (width) by 12 mm (height) in the anterior (interforaminal) area, allowing the placement of 3.3 (endosseous diameter) by 10 mm (length) implants
* Opposing dentition: complete denture on a edentulous maxilla
* Physical status (PS) 1 and 2 (American Society of Anesthesiologists)
Exclusion Criteria
* Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance to the protocol
* Any disorder that would interfere with wound healing or represent a contraindication for oral surgery such as, but not limited to, uncontrolled diabetes or conditions resulting in or requiring immunosuppression, radiation, chemotherapy, frequent use of antibiotics or antiresorptive medication such as bisphosphonates
* Pregnancy or lactation
* Heavy smoking habit with \> 20 cig/d
* Severe bruxism or clenching habits, present oro-facial pain
* At site level:
* Ridge defects requiring staged bone augmentation procedures (simultaneous Guided Bone Regeneration (GBR) within the ridge contour allowed)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beat Wallkamm, Dr
Role: PRINCIPAL_INVESTIGATOR
Private Practice
Martin Schimmel, Prof
Role: STUDY_DIRECTOR
University of Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Private Practice Dr. B. Wallkamm
Langenthal, Canton of Bern, Switzerland
University of Bern
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mini 1286_2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.